Latest Conference Articles

Jonathan Spergel, MD, PhD, and his team linked eosinophilic esophagitis to the condition-based theory. What others are part of the atopic march?

While multi-faceted approaches have been shown to be cost-effective, realistically they can be costly and impractical to implement. But environmental and educational interventions hold some promise.

The president of the American College of Allergy, Asthma & Immunology talked the session's future impact, upcoming therapies, and what his favorite lectures were.

African Americans have a 2.5-fold greater chance for developing asthma and a 1.8-fold greater chance for developing eczema, but ironically have a lower chance of receiving a FA diagnosis compared to white children.

Despite being the traditional practice, increasing inhaled controller therapy doses during yellow-zone episodes does not stop asthma exacerbations.

A study of nearly 2000 pediatric ICU admissions found that peanuts drive the most food-induced allergic reactions.

Re-examination revealed that alpha-gal allergy resulted in a change in the identification of definitive anaphylaxis triggers in 25% of cases.

Patients with a peanut allergy that can only tolerate low doses of oral immunotherapy can still achieve desensitization.

The synthetic vitamin B9 is a common prenatal treatment to prevent birth defects, but may not be as safe as its natural form.

While the data have been met with conflicting opinions, environmental interventions for allergens in the home hold potential for asthma.

The researcher from Ghent University in Belgium discussed the improved quality of life patient with severe nasal polyps experience with monoclonal antibodies.

Persistent cow's milk allergy may negatively impact height, weight, and BMI through adolescence.

Policy interventions and medication are the best available methods for improving the negative impact pollutants have on patients.

Improving asthma management in schools not only benefits pediatric patients' health, but improves attendance rates.

Those with blood type B or AB are an estimated 5-fold less likely to be diagnosed with red meat allergy.

The condition was found to be linked in pediatric patients who already suffer from asthma, atopic dermatitis, or food allergies, and can lead to children developing allergic rhinitis.

New study results compound on previous evidence of an association between tick bites and red meat allergy.

Early allergen sensitization is associated with an increased risk of viral infections and the development of childhood asthma.

Alexia Beauregard, MS, RD, CSP, LD, explains how a food allergy specialist dietitian could make a life-saving difference in helping families understand food allergy.

As telehealth becomes more widely used, the role dietitians play in multidisciplinary teams for the treatment of allergy has increased.

The FDA previously approved DUPIXENT in the US for the treatment of adults with moderate-to-severe atopic dermatitis.

Patricia Dickson, M.D., discusses similarities between variations of MPS and the both the benefits and challenges of being a researcher in the rare disease community.

Alexy V. Pshezhetsky, Ph.D., professor at the University of Montreal. sits down at WORLDSymposium to stress the importance of researcher involvement throughout the rare disease community.

Hartmann Wellhoefer, M.D., head of medical affairs at Shire, sits down with RDR at the 14th Annual WORLDSymposium to discuss the company's recent data for lysosomal storage diseases.

With no real standard-of-care for Sanfilippo syndrome patients, Brian Bigger, Ph.D., discusses the sense of urgency he and his colleagues feel while researching.

BioMarin presented interim data at the 14th Annual WORLDSymposium in San Diego from a Phase 1/2 trial for BMN 250 in MPS IIIB.

ArmaGen reported full 52-week results from a Phase 2 proof-of-concept study with AGT-181 in MPS I.

Rare Disease Report sits down with Simon Heales, Ph.D., Professor of Clinical Chemistry at Great Ormond Street Children’s Hospital in London who discusses a potential link between Gaucher disease and Parkinson’s disease.